Belsomra for sleep online prescriptions

Belsomra (suvorexant) is an oral medication approved by the U.S. Food and Drug Administration (FDA) in 2014 to treat insomnia in adults, including difficulties with sleep onset (falling asleep) and/or sleep maintenance (staying asleep). It’s also prescribed off-label to treat opioid use disorder (OUD).

Belsomra belongs to a class of drugs called orexin receptor antagonists (ORAs), which work by suppressing the activity of orexin, a neurotransmitter that promotes wakefulness. By blocking orexin, Belsomra helps regulate the sleep-wake cycle, making it easier to fall asleep and stay asleep.

Belsomra is only available as a brand-name drug. There’s no generic available.

To get a prescription for Belsomra online, you need to consult a licensed healthcare provider who can write prescriptions, such as a physician assistant/associate (PA), nurse practitioner (NP), or medical doctor (MD). You can find providers who specialize in treating insomnia on Klarity Health. Many have appointments available in as little as 24 hours.*

During your telehealth visit, your provider will evaluate your symptoms and medical history to determine if Belsomra is a medically necessary treatment option for you. If prescribed, your Belsomra prescription will be sent to your preferred pharmacy for pickup or home delivery.

Note in some states, a provider is required to see you at least once in person before they can prescribe medication. Check the Center for Connected Health Policy site for your state’s requirements.

Learn more about insomnia treatment.

The most common side effects of Belsomra include drowsiness, headache, and dizziness. Abnormal dreams, cough, diarrhea, dry mouth, increased cholesterol, and upper respiratory tract infection can also occur. Less common but serious side effects include:

• Sleep hallucinations 
• Sleep paralysis (temporary inability to move or speak when falling asleep or waking up)
• Impaired alertness or motor coordination
• Complex sleep behaviors, including sleepwalking or sleep-driving
• Worsening of depression or suicidal thoughts
• Breathing problems
• Cataplexy (sudden muscle weakness)

When taking Belsomra, avoid driving or using heavy machinery until you feel fully alert the next day. 

Belsomra may not be safe for everyone. People who have narcolepsy or who are pregnant or breastfeeding shouldn’t take it. Its effects on breast milk are unknown. 

If you take certain medications, including other CNS depressants (for example alcohol or benzodiazepines) or moderate CYP3A inhibitors (such as ritonavir, ketoconazole, itraconazole, erythromycin, clarithromycin, or fluconazole), your health provider may adjust your dosage of either Belsomra or the other medication to reduce your risk of side effects. Belsomra can also interact with digoxin and strong CYP3A inducers. It shouldn’t be combined with alcohol, because the added sedative effect can cause added psychomotor impairment.

Belsomra is a Schedule IV controlled substance, which means it has a risk of abuse or dependence. If you’re considering Belsomra, ensure your healthcare provider is aware of all your current prescription drugs, over-the-counter supplements, and health conditions. They can determine if Belsomra is the safest option for you. 

If you take Belsomra and your insomnia doesn’t go away within 7 to 10 days, talk to your healthcare provider.

If you take Belsomra for sleep and have any side effects, work with your provider and consider reporting negative side effects to the FDA by visiting MedWatch or calling 1-800-FDA-1088.